HealthStream Inc (HSTM)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $855.77M
Last updated: Nov 17, 2026 at 11:05 AM ET
HealthStream Inc (HSTM) Financials: Revenue, Profit and Cash Flow
HealthStream reported revenue of $304.06M for the fiscal year ended Dec 31, 2025, up 4.3% from the year before. That year, net income was $18.34M with a net margin of 6.0%, operating cash flow was $63.32M and free cash flow was $31.16M. The quarter ended Sep 30, 2026 had revenue of $83.31M and net income of $5.37M.
Revenue and Margins
The operating margin was 6.7% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $192.12M, a compound annual rate of 5.2%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $304.06M | +4.3% | 64.7% | 6.7% | 6.0% |
| Dec 2024 | $291.65M | +4.5% | 66.4% | 7.3% | 6.9% |
| Dec 2023 | $279.06M | +4.6% | 65.9% | 5.7% | 5.5% |
| Dec 2022 | $266.83M | +3.9% | 65.8% | 4.7% | 4.5% |
| Dec 2021 | $256.71M | +4.9% | 64.5% | 3.1% | 2.3% |
| Dec 2020 | $244.83M | -3.7% | 63.5% | 6.5% | 5.8% |
| Dec 2019 | $254.11M | +9.7% | 59.1% | 5.8% | 6.2% |
| Dec 2018 | $231.62M | +7.8% | 58.5% | 6.7% | 13.9% |
| Dec 2017 | $214.90M | +11.9% | 59.4% | 4.4% | 4.7% |
| Dec 2016 | $192.12M | N/A | 61.0% | 3.7% | 2.0% |
Income Statement
In the fiscal year ended Dec 2025, net income fell 8.3% from the year before. In the quarter ended Sep 2026, net income fell 11.8% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $304.06M | $291.65M | $279.06M | $266.83M | $256.71M | $244.83M | $254.11M | $231.62M | $214.90M | $192.12M |
| Cost of revenue | $107.21M | $97.94M | $95.02M | $91.14M | $91.03M | $89.33M | $103.89M | $96.01M | $87.21M | $74.97M |
| Gross profit | $196.85M | $193.71M | $184.04M | $175.68M | $165.68M | $155.49M | $150.22M | $135.60M | $127.69M | $117.16M |
| Research and development | $50.98M | $48.89M | $45.54M | $44.28M | $41.66M | $32.30M | $29.11M | $25.73M | $24.15M | $24.23M |
| Operating income | $20.24M | $21.29M | $16.02M | $12.45M | $8.05M | $15.82M | $14.72M | $15.49M | $9.41M | $7.17M |
| Net income | $18.34M | $20.01M | $15.21M | $12.09M | $5.84M | $14.09M | $15.77M | $32.22M | $10.00M | $3.75M |
| EBITDA | $75.99M | $74.69M | $68.73M | $63.69M | $53.75M | $56.78M | $54.10M | $48.47M | $34.19M | $28.12M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $83.31M | $83.73M | $81.20M | $79.71M | $76.47M | $74.40M | $73.48M | $74.23M | $73.09M | $71.56M | $72.76M | $70.58M |
| Gross profit | $53.30M | $54.72M | $53.45M | $50.86M | $49.97M | $48.03M | $48.00M | $49.12M | $48.63M | $47.82M | $48.14M | $46.57M |
| Operating income | $6.59M | $8.32M | $7.51M | $2.40M | $7.57M | $5.89M | $4.38M | $4.69M | $6.50M | $4.41M | $5.69M | $4.26M |
| Net income | $5.37M | $6.67M | $5.91M | $2.54M | $6.09M | $5.39M | $4.33M | $4.89M | $5.72M | $4.17M | $5.23M | $4.59M |
Balance Sheet
As of Dec 2025, cash and equivalents of $36.16M were 6.9% of total assets of $520.37M, against total liabilities of $166.35M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $520.37M | $510.77M | $499.94M | $497.74M | $486.75M | $500.31M | $489.54M | $441.95M | $411.12M | $396.00M |
| Current assets | $119.66M | $153.12M | $130.21M | $114.38M | $106.84M | $114.72M | $224.57M | $241.43M | $199.73M | $177.44M |
| Cash and equivalents | $36.16M | $59.47M | $40.33M | $46.02M | $46.91M | $36.57M | $131.54M | $134.32M | $84.77M | $49.63M |
| Total liabilities | $166.35M | $151.41M | $159.19M | $163.68M | $147.73M | $166.25M | $151.38M | $123.00M | $110.95M | $109.89M |
| Short-term debt | N/A | $2.80M | $2.97M | $2.84M | $21.41M | $28.93M | $34.86M | $32.30M | $27.28M | $23.30M |
| Shareholder equity | $354.02M | $359.36M | $340.75M | $334.06M | $339.02M | $334.06M | $338.17M | $318.95M | $300.17M | $286.11M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $565.85M | $521.60M | $527.44M | $520.37M | $499.93M | $500.15M | $524.04M | $510.77M | $502.83M | $499.56M | $511.61M | $499.94M |
| Total liabilities | $163.91M | $164.99M | $175.45M | $166.35M | $150.74M | $149.58M | $161.23M | $151.41M | $147.35M | $150.34M | $166.75M | $159.19M |
| Cash and equivalents | $58.96M | $46.17M | $48.71M | $36.16M | $53.54M | $52.10M | $77.29M | $59.47M | $57.49M | $46.13M | $52.41M | $40.33M |
| Shareholder equity | $401.94M | $356.61M | $351.99M | $354.02M | $349.19M | $350.57M | $362.81M | $359.36M | $355.48M | $349.21M | $344.85M | $340.75M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 49.2% of operating cash flow. Dividends and share repurchases together came to 108.3% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $63.32M | $57.66M | $63.97M | $51.19M | $42.38M | $35.87M | $65.66M | $43.25M | $46.71M | $24.23M |
| Capital expenditures | $32.16M | $28.14M | $28.01M | $25.10M | $25.35M | $18.80M | $36.51M | $18.45M | $15.11M | $13.79M |
| Free cash flow | $31.16M | $29.52M | $35.96M | $26.09M | $17.04M | $17.07M | $29.15M | $24.80M | $31.60M | $10.45M |
| Dividends paid | $3.73M | $3.40M | $3.06M | $0 | $19.00K | $40.00K | $96.00K | $32.40M | $58.00K | $58.00K |
| Share repurchases | $30.02M | $0 | $8.93M | $23.14M | $5.01M | $20.02M | $0 | $0 | N/A | N/A |
| Investing cash flow | -$50.35M | -$33.97M | -$56.60M | -$28.39M | -$25.72M | -$110.41M | -$67.52M | $36.56M | -$11.58M | -$56.66M |
| Financing cash flow | -$36.27M | -$4.52M | -$13.04M | -$23.70M | -$6.21M | -$20.49M | -$916.00K | -$30.25M | $1.00K | $46.00K |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $17.39M | $13.43M | $27.14M | $13.19M | $18.03M | $5.02M | $27.07M | $11.16M | $19.11M | $6.45M | $20.94M | $13.81M |
| Capital expenditures | $7.41M | $8.43M | $7.47M | $6.59M | $7.52M | $9.03M | $8.85M | $6.84M | $6.84M | $6.71M | $7.76M | $6.60M |
| Free cash flow | $9.98M | $5.00M | $19.67M | $6.60M | $10.51M | -$4.00M | $18.23M | $4.32M | $12.27M | -$254.00K | $13.18M | $7.21M |
Frequently Asked Questions About HSTM
What is HealthStream's annual revenue?
HealthStream reported revenue of $304.06M for the fiscal year ended Dec 31, 2025.
How fast is HealthStream's revenue growing?
Revenue was up 4.3% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 4.5%.
Is HealthStream profitable?
Yes. HealthStream reported net income of $18.34M for the fiscal year ended Dec 31, 2025, with a net margin of 6.0%.
How much free cash flow does HSTM generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $63.32M minus capital expenditures of $32.16M produced free cash flow of $31.16M.
How much debt does HealthStream have?
The balance sheet dated Dec 31, 2025 reported cash and equivalents of $36.16M.
HSTM pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts